Tactiva Therapeutics
1 known investors
Tactiva Therapeutics develops next-generation adoptive cell therapy for cancer by re-programming patients' own T cells and hematopoietic stem cells with T cell receptors (both CD4-TCRs and CD8-TCRs) to recognize and attack tumors. Its platform targets solid tumors, aiming to provide sustained and durable remission for cancer patients.
Investors · 1
Frequently asked questions
- What does Tactiva Therapeutics do?
- Tactiva Therapeutics develops next-generation adoptive cell therapy for cancer by re-programming patients' own T cells and hematopoietic stem cells with T cell receptors (both CD4-TCRs and CD8-TCRs) to recognize and attack tumors. Its platform targets solid tumors, aiming to provide sustained and durable remission for cancer patients.
- Who are Tactiva Therapeutics's investors?
- Tactiva Therapeutics's investors include Panacea Venture.